Skip to main content
Article thumbnail
Location of Repository

Clinical Studies

By Da Cameron, Dr Camidge, J Oyee and M Hirsch


Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cance

Topics: cost effectiveness, advanced breast cancer, Faslodex, fulvestrant, hormone receptor positive Breast cancer is the most common form of malignancy among women in western
Year: 2013
OAI identifier: oai:CiteSeerX.psu:
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.